Newbury Pharmaceuticals AB (publ)

Stockholm Stock Exchange NEWBRY.ST

Newbury Pharmaceuticals AB (publ) Net Cash Used For Investing Activities for the year ending August 31, 2024

Newbury Pharmaceuticals AB (publ) Net Cash Used For Investing Activities is NA for the year ending August 31, 2024. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.
  • Newbury Pharmaceuticals AB (publ) Net Cash Used For Investing Activities for the year ending August 31, 2023 was USD -78.36 K.
Key data
Date Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities Dividends Paid Capital Expenditure
Market news
SV Wall Street
Stockholm Stock Exchange: NEWBRY.ST

Newbury Pharmaceuticals AB (publ)

CEO Mr. Lars Minor
IPO Date Feb. 4, 2022
Location Sweden
Headquarters Scheeletorget 1
Employees 6
Sector Health Care
Industries
Pharmaceuticals Biotechnology Drugstores & Retail Pharmacies
Description

Newbury Pharmaceuticals AB (publ) operates as hybrid pharmaceutical company in Sweden, and Scandinavian market. It offers oncology, rare diseases, neurology, and other treatment products. The company was incorporated in 2020 and is based in Lund, Sweden.

StockViz Staff

February 5, 2025

Any question? Send us an email